首页> 外文期刊>The Psychiatric Clinics of North America >Evidence-based somatic treatment of depression in adults
【24h】

Evidence-based somatic treatment of depression in adults

机译:基于证据的成人抑郁症躯体治疗

获取原文
获取原文并翻译 | 示例
           

摘要

This article reviews recent studies and controversies about the effectiveness of antjdepressant medications for depression. These medications are used for treatment of a swide variety of noncfepressive conditions. Most notably, selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) are often prescribed for most anxiety disorders, and they are clearly effective in this sphere, with robust differences between active drugs and placebos in controlled clinical trials. As one studies the contentious literature on antidepressants for depression, it is important to not lose sight of the fact that the very term "antidepres-sant" has become anachronistic. These drugs are actually broad-spectrum emotional and physical pain^relieving agents with efficacy in depression, anxiety, insomnia, as well several nonpsychiatric pain syndromes such as migraines, irritable bowel syndrome, neuropathies, and fibromyalgia.
机译:本文回顾了有关抗抑郁药对抑郁症有效性的最新研究和争议。这些药物用于治疗多种非压迫性疾病。最值得注意的是,选择性5-羟色胺再摄取抑制剂(SSRIs)和5-羟色胺-去甲肾上腺素再摄取抑制剂(SNRIs)通常被指定用于大多数焦虑症,并且在此领域中它们显然是有效的,在受控临床试验中活性药物和安慰剂之间存在明显差异。在研究有关抑郁症抗抑郁药的有争议的文献时,重要的是不要忽视“抗抑郁药”这一术语已经过时的事实。这些药物实际上是广谱的情绪和身体疼痛缓解剂,可有效治疗抑郁症,焦虑症,失眠症以及一些非精神病性疼痛综合征,例如偏头痛,肠易激综合症,神经病和纤维肌痛。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号